| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |